A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease

fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults

NCT00800553 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)

NCT00874939 ·Status: TERMINATED ·Phase: PHASE1

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

NCT01548287 ·Status: COMPLETED ·Phase: PHASE2

A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease

NCT00291421 ·Status: COMPLETED

The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

NCT01921972 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease

NCT01054976 ·Status: COMPLETED ·Phase: PHASE4

Improving Sleep and Cognition in Alzheimer's Disease

NCT05200208 ·Status: COMPLETED ·Phase: NA

Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study

NCT00216593 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255 ·Status: COMPLETED ·Phase: PHASE2

Sleep Trial to Prevent Alzheimer's Disease

NCT04629547 ·Status: RECRUITING ·Phase: PHASE2

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

NCT00035204 ·Status: COMPLETED ·Phase: PHASE4

Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly

NCT00954616 ·Status: COMPLETED

Monitoring Drug Efficacy in Patients with Alzheimer's Disease

NCT05801380 ·Status: RECRUITING

A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

NCT00297362 ·Status: COMPLETED

Effects of a Nutraceutic Compound on Cognitive Impairment

NCT06200883 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease

NCT03056495 ·Status: TERMINATED ·Phase: PHASE1

MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)

NCT00420420 ·Status: COMPLETED ·Phase: PHASE2

Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine

NCT01009476 ·Status: COMPLETED

A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease

NCT01734395 ·Status: COMPLETED

Treatment of Language and Memory in Patients With Alzheimer's Disease

NCT00593372 ·Status: COMPLETED ·Phase: PHASE1

Cholinergic Health After Menopause (CHAMP)

NCT04129060 ·Status: COMPLETED ·Phase: EARLY_PHASE1

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

NCT00299676 ·Status: COMPLETED

Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease

NCT00104442 ·Status: COMPLETED ·Phase: PHASE4

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

NCT01181921 ·Status: TERMINATED ·Phase: PHASE4

Mirtazapine in Alzheimer-associated Weight Loss

NCT01505504 ·Status: COMPLETED